Embecta Corp. (EMBC) to Distribute Quarterly Dividend of $0.01 on September 15th

Embecta Corp. (NASDAQ:EMBC) declared a quarterly dividend on Tuesday, August 4th. Stockholders of record on Thursday, August 27th will be given a dividend of 0.01 per share on Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Thursday, August 27th.

Embecta has a payout ratio of 1.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Embecta to earn $1.76 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.3%.

Embecta Price Performance

Shares of NASDAQ:EMBC opened at $4.99 on Tuesday. The stock has a market capitalization of $282.73 million, a P/E ratio of 3.37 and a beta of 0.81. The business has a 50-day moving average of $3.74 and a two-hundred day moving average of $6.16. Embecta has a fifty-two week low of $2.77 and a fifty-two week high of $15.55.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.29. The business had revenue of $271.70 million for the quarter, compared to the consensus estimate of $254.53 million. Embecta had a negative return on equity of 19.25% and a net margin of 8.59%.The firm’s revenue was down 8.1% compared to the same quarter last year. During the same period last year, the business earned $1.12 EPS. Embecta has set its FY 2026 guidance at 1.800-1.900 EPS. As a group, research analysts expect that Embecta will post 1.84 EPS for the current fiscal year.

Analysts Set New Price Targets

EMBC has been the subject of a number of research reports. Zacks Research raised shares of Embecta from a “strong sell” rating to a “hold” rating in a report on Friday, July 17th. Bank of America dropped their price objective on shares of Embecta from $11.00 to $3.00 and set an “underperform” rating on the stock in a report on Monday, May 18th. Wall Street Zen lowered shares of Embecta from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings cut shares of Embecta from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. Finally, Mizuho lowered their price target on Embecta from $12.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $11.00.

About Embecta

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.